Matthew O'Donnell is the Dean of the University of Washington's College of Engineering. He came to the UW in September 2006 from the University of Michigan, where he was chair of the Department of Biomedical Engineering.
O'Donnell is a physicist by training with undergraduate through doctoral degrees from Notre Dame. He joined the University of Michigan faculty in 1990 as a professor of electrical engineering and computer science. In 1998, he was named the Jerry W. and Carol L. Levin Professor of Engineering and was appointed chair of the Biomedical Engineering Department in 1999. He won several engineering teaching awards at Michigan.
O'Donnell, who was elected to the National Academy of Engineering in February 2009, is an expert in ultrasound imaging, and other new diagnostic imaging technologies, including ultrafast optics, in vivo microscopy, catheter imaging of coronary arteries, optoacoustic arrays, and elasticity and molecular imaging. He is principal or co-principal investigator on numerous research projects funded by the National Institutes of Health and other federal agencies.
O'Donnell holds 50 patents and has authored or co-authored more than 200 publications. He is associate editor of the journal Ultrasonic Imaging, is a permanent member of the National Institutes of Health Imaging Study Section, a fellow of both IEEE and AIMBE, and a member of Sigma Xi, and the American Physical Society.
Earlier steps on his career path included postdoctoral fellowship and senior research associate positions at Washington University, St. Louis, a research fellowship at Yale University, and a decade of private-sector experience as a research and development physicist at General Electric in Schenectady, New York.
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”]
Broad claims covering delivery of therapeutics using engineered... Read more »
I don’t have five pithy things to tell entrepreneurs in Michigan, but I do have one comment based on my 16 years in Ann Arbor trying to help commercialize biotech/medtech innovations... Read more »
As the 21st century approaches its teenage years, so too does molecular medicine. Discovery of the structure of DNA more than 50 years ago launched the field of molecular biology. During... Read more »
© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.